PARTNER THERAPEUTICS, INC.
Federal contract awards won by PARTNER THERAPEUTICS, INC. (UEI J33MSDBJZMC6), 2021–2024 — public record from USAspending.
Showing awards with a value or ceiling of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.
6
awards
1
expiring in 12 months
2
agencies
Category award history
7 category awards to a new vendor (same agency and NAICS code, not this contract's own history) — latest: BRISTOL-MYERS SQUIBB COMPANY took Department of Veterans Affairs 325412 work from PARTNER THERAPEUTICS, INC. (May 19, 2026).
Agencies buying from PARTNER THERAPEUTICS, INC.
What PARTNER THERAPEUTICS, INC. has provided
Awards
PARTNER THERAPEUTICS: THE OVERALL OBJECTIVE OF THIS CONTRACT IS TO CONFIRM LEUKINE SAFETY IN SEPSIS PATIENTS, INFORM OPTIMAL LEUKINE DOSING, EXPLORE LEUKINE EFFICACY, AS WELL AS ADVANCE DEVELOPMENT OF MONOCYTE HUMAN LEUKOCYTE ANTIGEN-DR (MHLA-DR) AS
Department of Health and Human Services · $12,990,717 · Sep 30, 2024
LEUKINE 250MCG VIL INJ (5PKG)
Department of Health and Human Services · $133,514,342 · Sep 26, 2023
R&D FOR REPURPOSING FX06, A HOST-DIRECTED THERAPY, FOR TREATMENT OF SEVERE DISEASE IN PATIENTS WITH SUDAN VIRUS DISEASE (SVD) OR OTHER FILOVIRUSES AOI #22 REBOOT
Department of Health and Human Services · $748,039 · Sep 25, 2023
65 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS, FSS CONTRACT AWARD
Department of Veterans Affairs · No current value reported · Aug 15, 2023
LEUKINE 250MCG/VIL INJ
Department of Health and Human Services · $59,026,989 · Jul 25, 2022
PARTNER THERAPEUTICS, INC.: .: BARDA DRIVE : RESEARCH AND DEVELOPMENT OF DIAGNOSTIC TESTS FOR PATIENTS WITH SEPSIS AND IMMUNOPARALYSIS
Department of Health and Human Services · $748,912 · Sep 2, 2021